Acclinate, a Birmingham, Alabama-based healthcare technology company, has completed a $7 million Series A funding round. The funding round, led by Cencora Ventures and supported by Labcorp and Latimer Ventures, aimed to enhance Acclinate’s efforts to promote health equity and transform the inclusivity of clinical trials. Transforming Clinical Trials through Trust and Technology Acclinate’s strategy aims to build trust and foster long-term relationships with diverse communities. Their digital platform, NOWINCLUDED, is designed to educate and engage underrepresented groups in clinical trials, ensuring their inclusion in medical research. The platform serves as an educational tool while
SheMatters has recently secured a significant $2 million investment to launch its symptom tracker app. Founded by Jade Kearney (CEO) and Marguerite Pierce (COO), SheMatters is a pioneering digital health platform dedicated to improving maternal mortality in minority communities. The Symptom Tracker App The Symptom Tracker app is a new tool designed to empower expecting and new mothers in tracking vital signs and symptoms associated with serious complications. These complications could include preeclampsia, eclampsia, and Hemolysis, Elevated Liver enzymes and Low Platelets (HELLP) syndrome. This technology is especially crucial for
